Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

John Chan, MD

Photo of John Chan, MD
Title(s)Volunteer Clinical Professor, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
Address1600 Divisadero, #A7-47
San Francisco CA 94115
Phone415-353-9600
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    John K. Chan, MD, is the Director of Gynecologic Oncology and a specialist in the surgical and medical treatment of ovarian and other complex pelvic cancers at the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Chan oversees the Division’s activities and development in patient care, research and education. His research focuses on developing new therapies for gynecologic cancers, including genomic therapy and targeted biologic therapies, as well as investigating the role of tumor-initiating cells in ovarian cancer. He is involved in population-based studies examining treatment and health outcome of ovarian and uterine cancer patients. Dr. Chan has also recently been appointed the principal investigator one of the largest advanced ovarian cancer clinical trials in the world, which is currently under development at the National Cancer Institute.

    Collapse Research 
    Collapse research activities and funding
    Prophylactic oophorectomy: practice patterns &outcomes
    NIH R03AG032602Aug 15, 2008 - Jul 31, 2010
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disproportionate Impact of COVID-19 on Breast Cancer Diagnoses in Older Hispanic Women. Cureus. 2025 Aug; 17(8):e89593. Rohatgi AP, Tran N, Palkowski T, Liao CI, Darcy K, Tian C, Kapp DS, Chan JK. PMID: 40922826; PMCID: PMC12414135.
      View in: PubMed   Mentions:
    2. Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings. J Clin Pathol. 2025 Jul 18; 78(8):505-518. Tembhare P, Chen X, Chan JKC, Wood B, Naresh KN. PMID: 40318860.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Identifying and breaking barriers: Addressing disparities in the care of patients with gynecologic cancers. Gynecol Oncol Rep. 2025 Aug; 60:101799. Pothuri B, Muir M, Hurteau J, Farley J, Lightfoot MDS, Dewdney S, Castellano T, Chan JK, Ghamande S, Asante-Facey A, Stasenko M, Rimel BJ, Paskett ED. PMID: 40687922; PMCID: PMC12272470.
      View in: PubMed   Mentions:
    4. Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 Joint CSHP/EA4HP/SH workshop. Virchows Arch. 2025 Jun 24. Egan C, Song S, Liu WP, Wang Z, Xiao W, Chan JKC, Dirnhofer S, Fend F, Goodlad JR, Li X, Lorsbach R, Emile JF. PMID: 40550890.
      View in: PubMed   Mentions:    Fields:    
    5. Optimizing therapy for cervical cancers - Translating trial data into clinical decision-making. Gynecol Oncol. 2025 Aug; 199:47-50. Chan JK, Tewari K, Monk BJ, Herzog TJ, Coleman RL, McHale MT, Salani R, Francoeur AA, Kapp DS, Richardson MT. PMID: 40554179.
      View in: PubMed   Mentions:    Fields:    
    6. Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial. Clin Cancer Res. 2025 Jun 13; 31(12):2370-2378. Lee JM, Miller A, Rose PG, AlHilli M, Washington C, John VS, Shah CA, Matsuo K, Siedel J, Miller DS, Hopp EE, O'Shea A, Chan JK, Bradford LS, Morse CB, Nagel CI, Rodabaugh KJ, Kohn EC, Moore KN, Liu JF. PMID: 40192715; PMCID: PMC12165816.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    7. Treatment patterns and outcomes by mismatch repair/microsatellite instability status among patients with primary advanced or recurrent endometrial cancer in the United States. Future Oncol. 2025 Aug; 21(18):2299-2310. Chase DM, Kobayashi M, Gomez P, Lubinga SJ, Chan JK. PMID: 40497451; PMCID: PMC12323428.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    8. Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical Hysterectomy. JAMA Netw Open. 2025 05 01; 8(5):e2510717. Tarney CM, Tian C, Randall LM, Hussain SA, Javadian P, Cronin SP, Drayer S, Chan JK, Kapp DS, Hamilton CA, Leath CA, Benbrook DM, Washington CR, Moore KN, Bateman NW, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. PMID: 40372751; PMCID: PMC12082373.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study. Gynecol Oncol. 2025 Jun; 197:83-90. Johnson CR, Aryasomayajula C, Francoeur AA, Stewart C, Sia TY, Darcy KM, Tian C, Kapp DS, Liu YL, Chan JK. PMID: 40300426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Suicide rates of cervical cancer patients in the United States - Who is most at risk? A retrospective study of 69,493 patients. J Cancer Policy. 2025 Jun; 44:100586. Hunsberger KS, Kapp DS, Chan JK, Irwin CM, Chase DM. PMID: 40252834.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neoplasms. J Clin Pathol. 2025 Mar 19; 78(4):217-232. Attygalle AD, Karube K, Jeon YK, Cheuk W, Bhagat G, Chan JKC, Naresh KN. PMID: 39965886.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    12. Associated Trends in Obesity and Endometrioid Endometrial Cancer in the United States. Obstet Gynecol. 2025 Mar 01; 145(3):e107-e116. Francoeur AA, Liao CI, Chang J, Johnson CR, Clair K, Tewari KS, Kapp DS, Chan JK, Bristow RE. PMID: 39746203.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Trends in the incidence and mutational landscape of advanced uterine cancer. Int J Gynecol Cancer. 2025 Jan; 35(1):100013. Francoeur AA, Liao CI, Johnson CR, Argueta C, Tian C, Darcy KM, Kapp DS, Bristow RE, Chan JK. PMID: 39878271.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer. J Comp Eff Res. 2025 Jan; 14(1):e240133. Graybill WS, Vergote I, Pothuri B, Anttila M, O'Malley DM, Lorusso D, Haggerty AF, Fabbro M, Chan JK, Heitz F, Willmott LJ, Bruchim I, Zhuo Y, Estévez-García P, Monk BJ, Denys H, Knudsen A, Tinker AV, Sánchez LM, Provencher D, Barretina-Ginesta MP, Hartman J, Booth DV, González-Martín A. PMID: 39641537; PMCID: PMC11656343.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer. Int J Gynecol Cancer. 2024 11 04; 34(11):1727-1736. Huepenbecker S, Meyer LA, Craft M, Chan JK, Craggs C, Lambert P, Lin YG. PMID: 38950920.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Trends in Uterine Cancer Cases After the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet Gynecol. 2024 Dec 01; 144(6):829-831. Tran N, Chan JE, Stewart C, Johnson CR, Darcy K, Tian C, Kapp DS, Liao CI, Chan JK. PMID: 39601704; PMCID: PMC11606525.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    17. A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations. Int J Cancer. 2024 Oct 15; 155(8):1476-1486. Sarathkumara YD, Xian RR, Liu Z, Yu KJ, Chan JKC, Kwong YL, Lam TH, Liang R, Chiu B, Xu J, Hu W, Ji BT, Coghill AE, Kelly AM, Pfeiffer RM, Rothman N, Ambinder RF, Hildesheim A, Lan Q, Proietti C, Doolan DL. PMID: 38995124; PMCID: PMC11326961.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    18. Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy. Eur J Cancer. 2024 Sep; 208:114157. Vulsteke C, Chambers SK, Pérez MJR, Chan JK, Raaschou-Jensen N, Zhuo Y, Lorusso D, Herzog TJ, de la Motte Rouge T, Thomes Pepin JA, Braicu EI, Chen LM, Levy T, Barter JF, Pilar Barretina-Ginesta M, Joosens E, York W, Malinowska IA, González-Martín A, Monk BJ. PMID: 39013265.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    19. Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer. Gynecol Oncol. 2024 08; 187:249-252. Chan JK, Tewari K, Monk BJ, Herzog TJ, Coleman RL, Richardson MT, Kapp DS, Francoeur AA. PMID: 38838439.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues. Mod Pathol. 2024 Aug; 37(8):100512. Miranda RN, Amador C, Chan JKC, Guitart J, Rech KL, Medeiros LJ, Naresh KN, WHO fifth edition classification project. PMID: 38734236.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    21. What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms? J Hematop. 2024 Jun; 17(2):71-89. Attygalle AD, Chan JKC, Coupland SE, Du MQ, Ferry JA, de Jong D, Gratzinger D, Lim MS, Nicolae A, Ott G, Rosenwald A, Schuh A, Siebert R, WHO 5th Edition Classification Project. PMID: 38683440.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials. Gynecol Oncol. 2024 04; 183:103-114. Kopelman ZA, Tian C, Tumas J, Phippen NT, Tarney CM, Hope ER, Winkler SS, Jokajtys S, Kucera CW, Chan JK, Richardson MT, Kapp DS, Hamilton CA, Leath CA, Jones NL, Rocconi RP, Farley JH, Secord AA, Cosgrove CM, Powell MA, Klopp A, Walker JL, Fleming GF, Bateman NW, Conrads TP, Maxwell GL, Darcy KM. PMID: 38593674; PMCID: PMC11894812.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. In Reply. Obstet Gynecol. 2024 Apr 01; 143(4):e131. Bashi A, Somasegar S, Johnson C, Kapp DS, Chan JK. PMID: 38513251.
      View in: PubMed   Mentions:    Fields:    
    24. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States. Cancers (Basel). 2024 Mar 06; 16(5). Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA, Casablanca Y, Washington C, Chappell NP, Klopp AH, Shriver CD, Tarney CM, Bateman NW, Conrads TP, Maxwell GL, Phippen NT, Darcy KM. PMID: 38473428; PMCID: PMC10931267.
      View in: PubMed   Mentions:
    25. Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors. Gynecol Oncol. 2024 05; 184:224-235. Kucera CW, Chappell NP, Tian C, Richardson MT, Tarney CM, Hamilton CA, Chan JK, Kapp DS, Leath CA, Casablanca Y, Rojas C, Sitler CA, Wenzel L, Klopp A, Jones NL, Rocconi RP, Farley JH, O'Connor TD, Shriver CD, Bateman NW, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. PMID: 38340648; PMCID: PMC11361276.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes. Gynecol Oncol. 2024 05; 184:31-42. Winkler SS, Tian C, Casablanca Y, Bateman NW, Jokajtys S, Kucera CW, Tarney CM, Chan JK, Richardson MT, Kapp DS, Liao CI, Hamilton CA, Leath CA, Reddy M, Cote ML, O'Connor TD, Jones NL, Rocconi RP, Powell MA, Farley J, Shriver CD, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. PMID: 38277919.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. Uterine cancer among Asian Americans - Disparities & clinical characteristics. Gynecol Oncol. 2024 03; 182:24-31. Johnson CR, Liao CI, Tian C, Richardson MT, Duong K, Tran N, Winkler SS, Kapp DS, Darcy K, Chan JK. PMID: 38246043.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update. Leuk Lymphoma. 2024 Apr; 65(4):413-429. Attygalle AD, Chan JKC, Coupland SE, Du MQ, Ferry JA, Jong D, Gratzinger D, Lim MS, Naresh KN, Nicolae A, Ott G, Rosenwald A, Schuh A, Siebert R. PMID: 38189838.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Exploring U.S. Hispanic origin groups diagnosed with uterine cancer - Are there disparities? Gynecol Oncol. 2024 02; 181:118-124. Reddy M, Tian C, Liao CI, Winkler S, Johnson CR, Kapp DS, Darcy K, Chan JK. PMID: 38150836.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study. Gynecol Oncol. 2024 02; 181:54-59. Chan JK, Tian C, Kesterson JP, Lin KY, Darcy K, Richardson MT, Kapp DS, Monk BJ, McNally L, Landrum L, Copeland L, Walker JL, Wenham RM, Phippen N, Spirtos NM, Tewari K, Shahin M, Berry L, Bell JG. PMID: 38134754; PMCID: PMC11232492.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    31. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials. Gynecol Oncol. 2024 02; 181:1-7. Richardson MT, Barry D, Steinberg JR, Thirunavu V, Strom DE, Holder K, Zhang N, Turner BE, Magnani CJ, Weeks BT, Young AMP, Lu CF, Wolgemuth TR, Laasiri N, Squires NA, Anderson JN, Karlan BY, Chan JK, Kapp DS, Roque DR, Salani R. PMID: 38096673.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Impact of limiting reproductive rights of pregnant individuals with cancer in the United States. Gynecol Oncol. 2024 02; 181:183-185. Aryasomayajula C, Stewart C, Eakin C, Reiser H, Chow S, Kapp DS, Chan JK, Liao CI. PMID: 37981547; PMCID: PMC11076011.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis. Obstet Gynecol. 2023 10 01; 142(4):978-986. Somasegar S, Bashi A, Lang SM, Liao CI, Johnson C, Darcy KM, Tian C, Kapp DS, Chan JK. PMID: 37678887; PMCID: PMC10510793.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    34. Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer. Am J Clin Oncol. 2023 07 01; 46(7):314-322. Chan JK, Liu J, Song J, Xiang C, Wu E, Kalilani L, Hurteau JA, Thaker PH. PMID: 37106485; PMCID: PMC10281176.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023 04 03; 6(4):e238437. Kucera CW, Tian C, Tarney CM, Presti C, Jokajtys S, Winkler SS, Casablanca Y, Bateman NW, Mhawech-Fauceglia P, Wenzel L, Hamilton CA, Chan JK, Jones NL, Rocconi RP, O'Connor TD, Farley JH, Shriver CD, Conrads TP, Phippen NT, Maxwell GL, Darcy KM. PMID: 37067801; PMCID: PMC10111180.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    36. Trends in Incidence of Cancers Associated With Obesity and Other Modifiable Risk Factors Among Women, 2001-2018. Prev Chronic Dis. 2023 03 30; 20:E21. Cotangco KR, Liao CI, Eakin CM, Chan A, Cohen J, Kapp DS, Chan JK. PMID: 36996404; PMCID: PMC10109476.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    37. Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey. Cancer Control. 2023 Jan-Dec; 30:10732748231182795. Richardson MT, Attwood K, Smith G, Liang SY, LaVigne Mager K, Tewari KS, Coleman RL, Kapp DS, Chan JK, Monk BJ. PMID: 37646470; PMCID: PMC10469236.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Burkitt lymphoma. Nat Rev Dis Primers. 2022 12 15; 8(1):78. López C, Burkhardt B, Chan JKC, Leoncini L, Mbulaiteye SM, Ogwang MD, Orem J, Rochford R, Roschewski M, Siebert R. PMID: 36522349.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    39. The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study. Gynecol Oncol. 2022 Dec; 167(3):429-435. Chan JK, Tian C, Kesterson JP, Richardson MT, Lin K, Tewari KS, Herzog T, Kapp DS, Monk BJ, Casablanca Y, Hanjani P, Wenham RM, Walker J, McNally L, Copeland LJ, Robertson S, Lentz S, Spirtos NM, Bell JG. PMID: 36244828.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer. Obstet Gynecol. 2022 11 01; 140(5):758-767. Huepenbecker SP, Wright JD, Downer MK, Incerti D, Luhn P, Dolado I, Bastiere-Truchot L, Lin YG, Chan JK, Meyer LA. PMID: 36201776; PMCID: PMC9588544.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    41. The effect of COVID-19 on telehealth: Next steps in a post-pandemic life. Int J Gynaecol Obstet. 2022 12; 159(3):996-997. Liang SY, Richardson MT, Wong D, Chen T, Colocci N, Kapp DS, de Bruin M, Kurian A, Chan JK. PMID: 35976039; PMCID: PMC9538136.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    42. The oversimplification of uterine cancer classifications and risk factors. Am J Obstet Gynecol. 2023 01; 228(1):104-105. Eakin CM, Kapp DS, Chan JK. PMID: 36115447; PMCID: PMC10324023.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. The increasing incidence of stage IV cervical cancer in the USA: what factors are related? Int J Gynecol Cancer. 2022 Sep 06; 32(9):1115-1122. Francoeur AA, Liao CI, Caesar MA, Chan A, Kapp DS, Cohen JG, Salani R, Chan JK. PMID: 35981903.
      View in: PubMed   Mentions: 27     Fields:    
    44. Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting. Gynecol Oncol. 2022 11; 167(2):205-212. Bui A, Gehrig PA, Ghamande S, Rungruang BJ, Chan JK, Mysona DP. PMID: 36055814.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. The Role of Diet Compared to Physical Activity on Women's Cancer Mortality: Results From the Third National Health and Nutrition Examination Survey. Front Public Health. 2022; 10:853636. Chan JE, Caesar MA, Mann AK, Koh-Bell A, Richardson MT, Johnson CR, Kapp DS, Chan JK. PMID: 35979450; PMCID: PMC9376675.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer. Gynecol Oncol. 2022 09; 166(3):410-416. Pitiyarachchi O, Friedlander M, Java JJ, Chan JK, Armstrong DK, Markman M, Herzog TJ, Monk BJ, Backes F, Secord AA, Bonebrake A, Rose PG, Tewari KS, Lentz SS, Geller MA, Copeland LJ, Mannel RS. PMID: 35835612; PMCID: PMC9718158.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. In Reply. Obstet Gynecol. 2022 Jun 01; 139(6):1196-1197. Chan JK, Tian C, Kesterson JP, Monk BJ, Kapp DS, Davidson B, Robertson S, Copeland LJ, Walker JL, Wenham R, Casablanca Y, Spirtos NM, Tewari KS, Bell JG. PMID: 35675622.
      View in: PubMed   Mentions:    Fields:    
    48. Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecol Oncol. 2022 07; 166(1):90-99. Nolin AC, Tian C, Hamilton CA, Casablanca Y, Bateman NW, Chan JK, Cote ML, Shriver CD, Powell MA, Phippen NT, Conrads TP, Maxwell GL, Darcy KM. PMID: 35624045.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. The association of obesity with type I uterine cancer-is this an oversimplification? Am J Obstet Gynecol. 2022 09; 227(3):538-539. Eakin CM, Liao CI, Salani R, Cohen JG, Kapp DS, Chan JK. PMID: 35562051; PMCID: PMC9420798.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    50. Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. Int J Mol Sci. 2022 Apr 13; 23(8). Thierauf JC, Farahani AA, Indave BI, Bard AZ, White VA, Smith CR, Marble H, Hyrcza MD, Chan JKC, Bishop J, Shi Q, Ely K, Agaimy A, Martinez-Lage M, Nose V, Rivera M, Nardi V, Dias-Santagata D, Garg S, Sadow P, Le LP, Faquin W, Ritterhouse LL, Cree IA, Iafrate AJ, Lennerz JK. PMID: 35457138; PMCID: PMC9026998.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017. JAMA Netw Open. 2022 03 01; 5(3):e222530. Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. PMID: 35294540; PMCID: PMC8928005.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCellsPHPublic Health
    52. Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study. Gynecol Oncol Rep. 2022 Apr; 40:100936. Liao CI, Caesar MA, Lee D, Chan A, Darcy KM, Tian C, Kapp DS, Chan JK. PMID: 35169605; PMCID: PMC8829560.
      View in: PubMed   Mentions: 5  
    53. Symptoms of Women With High-Risk Early-Stage Ovarian Cancer. Obstet Gynecol. 2022 02 01; 139(2):157-162. Chan JK, Tian C, Kesterson JP, Monk BJ, Kapp DS, Davidson B, Robertson S, Copeland LJ, Walker JL, Wenham RM, Casablanca Y, Spirtos NM, Tewari KS, Bell JG. PMID: 34991145; PMCID: PMC9126568.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    54. The Healthcare Journey of Women With Advanced Gynecological Cancer From Diagnosis Through Terminal Illness: Qualitative Analysis of Progress Note Data. Am J Hosp Palliat Care. 2022 Sep; 39(9):1090-1097. Dillon EC, Chopra V, Mesghina E, Milki A, Chan A, Reddy R, Kapp DS, Silver BA, Chan JK. PMID: 34951820.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults. JNCI Cancer Spectr. 2021 12; 5(6). Abel MK, Mann AK, Sonawane K, Kapp DS, Deshmukh AA, Chan JK. PMID: 34993415; PMCID: PMC8713009.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    56. Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial. Gynecol Oncol. 2022 02; 164(2):278-287. Aghajanian C, Swisher EM, Okamoto A, Steffensen KD, Bookman MA, Fleming GF, Friedlander M, Moore KN, Tewari KS, O'Malley DM, Chan JK, Ratajczak C, Hashiba H, Wu M, Dinh MH, Coleman RL. PMID: 34930617; PMCID: PMC9399938.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    57. A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discov. 2022 02; 12(2):331-355. Pfister SM, Reyes-Múgica M, Chan JKC, Hasle H, Lazar AJ, Rossi S, Ferrari A, Jarzembowski JA, Pritchard-Jones K, Hill DA, Jacques TS, Wesseling P, López Terrada DH, von Deimling A, Kratz CP, Cree IA, Alaggio R. PMID: 34921008; PMCID: PMC9401511.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    58. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma. Sci Rep. 2021 12 08; 11(1):23664. Liu Z, Sarathkumara YD, Chan JKC, Kwong YL, Lam TH, Ip DKM, Chiu BC, Xu J, Su YC, Proietti C, Cooper MM, Yu KJ, Bassig B, Liang R, Hu W, Ji BT, Coghill AE, Pfeiffer RM, Hildesheim A, Rothman N, Doolan DL, Lan Q. PMID: 34880297; PMCID: PMC8655014.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    59. Human Papillomavirus Vaccination Trends and Disparities in the United States: Who Is Getting Left Behind? Sex Transm Dis. 2021 10 01; 48(10):714-719. Chan JK, Mann AK, Lee D, Rohatgi A, Chan C, Abel MK, Argueta C, Kapp DS. PMID: 34110737.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    60. Applying Artificial Intelligence to Gynecologic Oncology: A Review. Obstet Gynecol Surv. 2021 May; 76(5):292-301. Mysona DP, Kapp DS, Rohatgi A, Lee D, Mann AK, Tran P, Tran L, She JX, Chan JK. PMID: 34032861.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    61. Progress and trends in publication of oral and video presentations at the society of gynecologic oncology annual meeting from 2006 to 2016. Gynecol Oncol Rep. 2021 May; 36:100758. Milki AA, Cohen JG, Mann AK, Kapp DS, Chan JK. PMID: 33948477; PMCID: PMC8080448.
      View in: PubMed   Mentions:
    62. Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study. Gynecol Oncol. 2021 05; 161(2):470-476. Abel MK, Liao CI, Chan C, Lee D, Rohatgi A, Darcy KM, Tian C, Mann AK, Maxwell GL, Kapp DS, Chan JK. PMID: 33722415.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    63. Publication of oral and video presentations from the Society of Gynecologic Oncology annual meeting over 11 years - What characteristics were important? Gynecol Oncol Rep. 2021 Feb; 35:100688. Milki AA, Cohen JG, Kaur Mann A, Kapp DS, Chan JK. PMID: 33385054; PMCID: PMC7771100.
      View in: PubMed   Mentions: 4  
    64. Age and racial differences in the presentation of gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2021 02; 31(2):194-202. Diver E, Richardson M, Liao CI, Mann AK, Darcy KM, Tian C, Kapp DS, Chan JK. PMID: 33310882.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Oncol. 2020 12; 21(12):1661-1672. Rocconi RP, Grosen EA, Ghamande SA, Chan JK, Barve MA, Oh J, Tewari D, Morris PC, Stevens EE, Bottsford-Miller JN, Tang M, Aaron P, Stanbery L, Horvath S, Wallraven G, Bognar E, Manning L, Nemunaitis J, Shanahan D, Slomovitz BM, Herzog TJ, Monk BJ, Coleman RL. PMID: 33271095.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    66. Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer? Ann Surg Oncol. 2021 Jul; 28(7):3605-3615. Mysona DP, Ghamande S, She JX, Tran L, Tran P, Rungruang BJ, Chan JK, Bae-Jump V, Gehrig PA. PMID: 33155151.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter? J Gynecol Oncol. 2020 Nov; 31(6):e81. Chow S, Wong D, Liao CI, Mann A, Tian C, Darcy KM, Chan JK. PMID: 33078591; PMCID: PMC7593224.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance. Gynecol Oncol. 2020 12; 159(3):604-606. Chan JK, Liang SY, Kapp DS, Chan JE, Herzog TJ, Coleman RL, Monk BJ, Richardson MT. PMID: 32994055.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Relationship status and other demographic influences on survival in patients with ovarian cancer. Int J Gynecol Cancer. 2020 12; 30(12):1922-1927. Gardner AB, Sanders BE, Mann AK, Liao CI, Eskander RN, Kapp DS, Chan JK. PMID: 32920535.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    70. Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit. Gynecol Oncol. 2020 10; 159(1):118-128. Richardson MT, Mysona DP, Klein DA, Mann A, Liao CI, Diver EJ, Darcy KM, Tian C, She JX, Ghamande S, Van Le L, Kapp DS, Chan JK. PMID: 32828578.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Trends and survival outcomes of robotic, laparoscopic, and open surgery for stage II uterine cancer. Int J Gynecol Cancer. 2020 09; 30(9):1347-1355. Abel MK, Chan JK, Chow S, Darcy K, Tian C, Kapp DS, Mann AK, Liao CI. PMID: 32753561.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    72. Trends in the Utilization of Palliative Care in Patients With Gynecologic Cancer Who Subsequently Died During Hospitalization. Am J Hosp Palliat Care. 2021 Feb; 38(2):138-146. Milki A, Mann AK, Gardner A, Kapp DS, English D, Chan JK. PMID: 32633550.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    73. Human papillomavirus: The other invisible enemy. Gynecol Oncol. 2020 08; 158(2):254-255. Abel MK, Huh WK, Chan JK. PMID: 32518014; PMCID: PMC7275186.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    74. Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer. Gynecol Oncol Rep. 2020 Aug; 33:100581. Chan JK, Lakomy DS, McDonald Y, Kapp DS. PMID: 32551353; PMCID: PMC7292902.
      View in: PubMed   Mentions: 4  
    75. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecol Oncol. 2020 04; 157(1):67-77. Rojas C, Tian C, Powell MA, Chan JK, Bateman NW, Conrads TP, Rocconi RP, Jones NL, Shriver CD, Hamilton CA, Maxwell GL, Casablanca Y, Darcy KM. PMID: 32029291.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    76. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities. Gynecol Oncol. 2020 04; 157(1):121-130. Vaz J, Tian C, Richardson MT, Chan JK, Mysona D, Rao UN, Powell MA, Shriver CD, Hamilton CA, Casablanca Y, Maxwell GL, Darcy KM. PMID: 31954536.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One. 2019; 14(12):e0227197. Hsu CH, Chan JK, Yin CH, Lee CC, Chern CU, Liao CI. PMID: 31891634; PMCID: PMC6938371.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    78. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations. Lancet Oncol. 2020 02; 21(2):306-316. Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, Chan JKC, Li W, Liu W, Shih LY, Chuang WY, Kim WS, Tan W, Peng RJ, Laurensia Y, Cheah DMZ, Huang D, Cheng CL, Su YJ, Tan SY, Ng SB, Tang TPL, Han K, Wang VY, Jia WH, Pei Z, Li YJ, Gao S, Shi Y, Hu Z, Zhang F, Zhang B, Zeng YX, Shen H, He L, Ong CK, Lim ST, Chanock S, Kwong YL, Lin D, Rothman N, Khor CC, Lan Q, Bei JX, International NKTCL Working Group. PMID: 31879220.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    79. Does chemotherapy or radiation benefit surgical stage I uterine carcinosarcoma patients? Am J Obstet Gynecol. 2020 04; 222(4):383-384. Chow S, Chan JK, Kapp DS, Mann A, Liou WS, Liao CI. PMID: 31765639.
      View in: PubMed   Mentions: 3     Fields:    
    80. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clin Exp Metastasis. 2020 02; 37(1):107-113. Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK. PMID: 31758289.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    81. Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer. N Engl J Med. 2019 11 14; 381(20):1929-1939. Coleman RL, Spirtos NM, Enserro D, Herzog TJ, Sabbatini P, Armstrong DK, Kim JW, Park SY, Kim BG, Nam JH, Fujiwara K, Walker JL, Casey AC, Alvarez Secord A, Rubin S, Chan JK, DiSilvestro P, Davidson SA, Cohn DE, Tewari KS, Basen-Engquist K, Huang HQ, Brady MF, Mannel RS. PMID: 31722153; PMCID: PMC6941470.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCTClinical Trials
    82. Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer-is interval cytoreductive surgery still needed? Am J Obstet Gynecol. 2020 02; 222(2):170.e1-170.e11. Klein DA, Mann AK, Freeman AH, Liao CI, Kapp DS, Chan JK. PMID: 31421122.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer. J Clin Oncol. 2019 09 10; 37(26):2317-2328. Tewari KS, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ. PMID: 31216226; PMCID: PMC6879307.
      View in: PubMed   Mentions: 218     Fields:    Translation:HumansCTClinical Trials
    84. Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients. Gynecol Oncol. 2019 08; 154(2):420-425. Fuh KC, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS. PMID: 31229298; PMCID: PMC6941471.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    85. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2019 05; 20(5):636-648. Moore KN, Secord AA, Geller MA, Miller DS, Cloven N, Fleming GF, Wahner Hendrickson AE, Azodi M, DiSilvestro P, Oza AM, Cristea M, Berek JS, Chan JK, Rimel BJ, Matei DE, Li Y, Sun K, Luptakova K, Matulonis UA, Monk BJ. PMID: 30948273.
      View in: PubMed   Mentions: 259     Fields:    Translation:HumansCTClinical Trials
    86. Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer. Cancer Chemother Pharmacol. 2019 04; 83(4):717-726. Moore K, Chan JK, Secord AA, Patel MR, Callahan T, Guo W, Zhang ZY. PMID: 30680521.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    87. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. 2018 11 01; 132(18):1871-1878. Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D. PMID: 30082493; PMCID: PMC6213318.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    88. Hospital-acquired conditions after surgery for gynecologic cancer - An analysis of 82,304 patients. Gynecol Oncol. 2018 09; 150(3):515-520. Chan JK, Gardner AB, Mann AK, Kapp DS. PMID: 30037490.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    89. Metastatic gynecologic malignancies: advances in treatment and management. Clin Exp Metastasis. 2018 08; 35(5-6):521-533. Chan JK, Chow S, Bhowmik S, Mann A, Kapp DS, Coleman RL. PMID: 29931499.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    90. A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254). Gynecol Oncol. 2018 08; 150(2):247-252. Chan JK, Brady W, Monk BJ, Brown J, Shahin MS, Rose PG, Kim JH, Secord AA, Walker JL, Gershenson DM. PMID: 29921512; PMCID: PMC6235144.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    91. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. Gynecol Oncol. 2018 05; 149(2):318-323. Liao CI, Chow S, Chen LM, Kapp DS, Mann A, Chan JK. PMID: 29514737.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    92. Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection. J Clin Med. 2018 Mar 01; 7(3). Islamoglu H, Cao R, Teskey G, Gyurjian K, Lucar S, Fraix MP, Sathananthan A, Chan JK, Venketaraman V. PMID: 29494546; PMCID: PMC5867566.
      View in: PubMed   Mentions: 13  
    93. Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. Int J Gynecol Cancer. 2018 02; 28(2):338-345. Tarney CM, Tian C, Craig ER, Crothers BA, Chan JK, Gist GD, Bateman NW, Conrads TP, Hamilton CA, Larry Maxwell G, Darcy KM. PMID: 29232272.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    94. Disparities Associated With Inpatient Palliative Care Utilization by Patients With Metastatic Gynecologic Cancers: A Study of 3337 Women. Am J Hosp Palliat Care. 2018 Apr; 35(4):697-703. Rosenfeld EB, Chan JK, Gardner AB, Curry N, Delic L, Kapp DS. PMID: 29141457.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    95. Clear Cell Ovarian Cancer: Optimum Management and Prognosis Remain Hazy. Gynecol Oncol. 2017 11; 147(2):237-239. Chan JK, Kapp DS. PMID: 29096823.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer. Gynecol Oncol Rep. 2017 Nov; 22:43-44. Minor DR, Moores SP, Chan JK. PMID: 29034306; PMCID: PMC5633818.
      View in: PubMed   Mentions: 5  
    97. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol. 2018 04; 149(1):12-21. Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM. PMID: 28800945; PMCID: PMC6863162.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    98. A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 09; 146(3):554-559. Chan JK, Deng W, Higgins RV, Tewari KS, Bonebrake AJ, Hicks M, Gaillard S, Ramirez PT, Chafe W, Monk BJ, Aghajanian C. PMID: 28728751; PMCID: PMC5728988.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    99. Factors associated with oophorectomy in children with benign ovarian masses. Int J Gynaecol Obstet. 2017 09; 138(3):356-357. Kapp DS, Rosenfeld EB, Chan JE, Chan JK. PMID: 28556186.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    100. The fourth edition of the head and neck World Health Organization blue book: editors' perspectives. Hum Pathol. 2017 08; 66:10-12. El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. PMID: 28583885.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    101. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2017 06; 18(6):779-791. Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. PMID: 28438473; PMCID: PMC5715461.
      View in: PubMed   Mentions: 268     Fields:    Translation:HumansCTClinical Trials
    102. CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study. Clin Cancer Res. 2017 Jul 15; 23(14):3684-3691. Ng CS, Zhang Z, Lee SI, Marques HS, Burgers K, Su F, Bauza J, Mannel RS, Walker JL, Huh WK, Rubin SC, DiSilvestro P, Martin LP, Chan JK, Bookman MA, Coleman RL, Lee TY. PMID: 28174234; PMCID: PMC5720368.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    103. T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4. Am J Clin Pathol. 2017 Feb 01; 147(2):188-203. Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, Said J, Natkunam Y. PMID: 28395105; PMCID: PMC6248696.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    104. Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. Am J Clin Pathol. 2017 Feb 01; 147(2):204-216. Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y. PMID: 28395106; PMCID: PMC6248572.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    105. Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology. Am J Clin Pathol. 2017 02 01; 147(2):124-128. Natkunam Y, Gratzinger D, de Jong D, Chadburn A, Goodlad JR, Chan JK, Said J, Jaffe ES. PMID: 28395103.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    106. HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3. Am J Clin Pathol. 2017 Feb 01; 147(2):171-187. Chadburn A, Said J, Gratzinger D, Chan JK, de Jong D, Jaffe ES, Natkunam Y, Goodlad JR. PMID: 28395104; PMCID: PMC6248411.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    107. EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. Am J Clin Pathol. 2017 Feb 01; 147(2):129-152. Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES. PMID: 28395107; PMCID: PMC6248636.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    108. B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2. Am J Clin Pathol. 2017 Feb 01; 147(2):153-170. de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y. PMID: 28395108; PMCID: PMC6248547.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    109. Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study. BMC Med Ethics. 2016 10 21; 17(1):63. Pulford DJ, Harter P, Floquet A, Barrett C, Suh DH, Friedlander M, Arranz JA, Hasegawa K, Tada H, Vuylsteke P, Mirza MR, Donadello N, Scambia G, Johnson T, Cox C, Chan JK, Imhof M, Herzog TJ, Calvert P, Wimberger P, Berton-Rigaud D, Lim MC, Elser G, Xu CF, du Bois A. PMID: 27769273; PMCID: PMC5073453.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    110. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients - An analysis of NRG Oncology/Gynecologic Oncology Group trials. Gynecol Oncol. 2016 Dec; 143(3):490-495. Chan JK, Java JJ, Fuh K, Monk BJ, Kapp DS, Herzog T, Bell J, Young R. PMID: 27771168; PMCID: PMC5728987.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    111. Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia. Obstet Gynecol. 2016 Sep; 128(3):535-542. Osborne RJ, Filiaci VL, Schink JC, Mannel RS, Behbakht K, Hoffman JS, Spirtos NM, Chan JK, Tidy JA, Miller DS. PMID: 27500329; PMCID: PMC4993663.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    112. The influence of age and other prognostic factors associated with survival of ovarian immature teratoma - A study of 1307 patients. Gynecol Oncol. 2016 09; 142(3):446-51. Chan JK, Gardner AB, Chan JE, Guan A, Alshak M, Kapp DS. PMID: 27423379.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    113. Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer. N Engl J Med. 2016 06 30; 374(26):2603-4. Chan JK, Brady MF, Monk BJ. PMID: 27355549.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    114. Racial disparities in presentation and survival of ovarian yolk sac cancer patients: a study of 423 women. Am J Obstet Gynecol. 2016 08; 215(2):248-9. Chan JK, Gardner AB, Liao CI, Chan J, Guan A, Alshak M, Kapp DS. PMID: 27156674.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. Inherited Mutations in Women With Ovarian Carcinoma. JAMA Oncol. 2016 Apr; 2(4):482-90. Norquist BM, Harrell MI, Brady MF, Walsh T, Lee MK, Gulsuner S, Bernards SS, Casadei S, Yi Q, Burger RA, Chan JK, Davidson SA, Mannel RS, DiSilvestro PA, Lankes HA, Ramirez NC, King MC, Swisher EM, Birrer MJ. PMID: 26720728; PMCID: PMC4845939.
      View in: PubMed   Mentions: 363     Fields:    Translation:Humans
    116. Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma. JAMA Oncol. 2016 Mar; 2(3):370-2. Swisher EM, Harrell MI, Norquist BM, Walsh T, Brady M, Lee M, Hershberg R, Kalli KR, Lankes H, Konnick EQ, Pritchard CC, Monk BJ, Chan JK, Burger R, Kaufmann SH, Birrer MJ. PMID: 26847329; PMCID: PMC4865293.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    117. Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. N Engl J Med. 2016 Feb 25; 374(8):738-48. Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, Huh WK, O'Malley DM, Boente MP, Michael H, Monk BJ. PMID: 26933849; PMCID: PMC5081077.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCTClinical Trials
    118. Reply to F.M. Muggia. J Clin Oncol. 2016 Mar 10; 34(8):882-3. Chan JK, Monk BJ. PMID: 26834062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women. Hum Mol Genet. 2016 Feb 01; 25(3):620-9. Wang Z, Seow WJ, Shiraishi K, Hsiung CA, Matsuo K, Liu J, Chen K, Yamji T, Yang Y, Chang IS, Wu C, Hong YC, Burdett L, Wyatt K, Chung CC, Li SA, Yeager M, Hutchinson A, Hu W, Caporaso N, Landi MT, Chatterjee N, Song M, Fraumeni JF, Kohno T, Yokota J, Kunitoh H, Ashikawa K, Momozawa Y, Daigo Y, Mitsudomi T, Yatabe Y, Hida T, Hu Z, Dai J, Ma H, Jin G, Song B, Wang Z, Cheng S, Yin Z, Li X, Ren Y, Guan P, Chang J, Tan W, Chen CJ, Chang GC, Tsai YH, Su WC, Chen KY, Huang MS, Chen YM, Zheng H, Li H, Cui P, Guo H, Xu P, Liu L, Iwasaki M, Shimazu T, Tsugane S, Zhu J, Jiang G, Fei K, Park JY, Kim YH, Sung JS, Park KH, Kim YT, Jung YJ, Kang CH, Park IK, Kim HN, Jeon HS, Choi JE, Choi YY, Kim JH, Oh IJ, Kim YC, Sung SW, Kim JS, Yoon HI, Kweon SS, Shin MH, Seow A, Chen Y, Lim WY, Liu J, Wong MP, Lee VH, Bassig BA, Tucker M, Berndt SI, Chow WH, Ji BT, Wang J, Xu J, Sihoe AD, Ho JC, Chan JK, Wang JC, Lu D, Zhao X, Zhao Z, Wu J, Chen H, Jin L, Wei F, Wu G, An SJ, Zhang XC, Su J, Wu YL, Gao YT, Xiang YB, He X, Li J, Zheng W, Shu XO, Cai Q, Klein R, Pao W, Lawrence C, Hosgood HD, Hsiao CF, Chien LH, Chen YH, Chen CH, Wang WC, Chen CY, Wang CL, Yu CJ, Chen HL, Su YC, Tsai FY, Chen YS, Li YJ, Yang TY, Lin CC, Yang PC, Wu T, Lin D, Zhou B, Yu J, Shen H, Kubo M, Chanock SJ, Rothman N, Lan Q. PMID: 26732429; PMCID: PMC4731021.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    120. BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study. Gynecol Oncol. 2016 Mar; 140(3):443-9. Harter P, Johnson T, Berton-Rigaud D, Park SY, Friedlander M, Del Campo JM, Shimada M, Forget F, Mirza MR, Colombo N, Zamagni C, Chan JK, Imhof M, Herzog TJ, O'Donnell D, Heitz F, King K, Stinnett S, Barrett C, Jobanputra M, Xu CF, du Bois A. PMID: 26740259.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    121. The economic impact of surgical care for morbidly obese endometrial cancer patients: a nationwide study. Am J Obstet Gynecol. 2016 Apr; 214(4):498.e1-498.e6. Brooks RA, Blansit K, Young-Lin N, Usach I, Chen LM, Yu X, Kapp DS, Chan JK. PMID: 26478102.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    122. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279. Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, De Vivo I, McGlynn KA, Purdue MP, Rajaraman P, Adami HO, Ahlbom A, Albanes D, Amary MF, An SJ, Andersson U, Andriole G, Andrulis IL, Angelucci E, Ansell SM, Arici C, Armstrong BK, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Becker N, Benavente Y, Benhamou S, Berg C, Van Den Berg D, Bernstein L, Bertrand KA, Birmann BM, Black A, Boeing H, Boffetta P, Boutron-Ruault MC, Bracci PM, Brinton L, Brooks-Wilson AR, Bueno-de-Mesquita HB, Burdett L, Buring J, Butler MA, Cai Q, Cancel-Tassin G, Canzian F, Carrato A, Carreon T, Carta A, Chan JK, Chang ET, Chang GC, Chang IS, Chang J, Chang-Claude J, Chen CJ, Chen CY, Chen C, Chen CH, Chen C, Chen H, Chen K, Chen KY, Chen KC, Chen Y, Chen YH, Chen YS, Chen YM, Chien LH, Chirlaque MD, Choi JE, Choi YY, Chow WH, Chung CC, Clavel J, Clavel-Chapelon F, Cocco P, Colt JS, Comperat E, Conde L, Connors JM, Conti D, Cortessis VK, Cotterchio M, Cozen W, Crouch S, Crous-Bou M, Cussenot O, Davis FG, Ding T, Diver WR, Dorronsoro M, Dossus L, Duell EJ, Ennas MG, Erickson RL, Feychting M, Flanagan AM, Foretova L, Fraumeni JF, Freedman ND, Beane Freeman LE, Fuchs C, Gago-Dominguez M, Gallinger S, Gao YT, Gapstur SM, Garcia-Closas M, García-Closas R, Gascoyne RD, Gastier-Foster J, Gaudet MM, Gaziano JM, Giffen C, Giles GG, Giovannucci E, Glimelius B, Goggins M, Gokgoz N, Goldstein AM, Gorlick R, Gross M, Grubb R, Gu J, Guan P, Gunter M, Guo H, Habermann TM, Haiman CA, Halai D, Hallmans G, Hassan M, Hattinger C, He Q, He X, Helzlsouer K, Henderson B, Henriksson R, Hjalgrim H, Hoffman-Bolton J, Hohensee C, Holford TR, Holly EA, Hong YC, Hoover RN, Horn-Ross PL, Hosain GM, Hosgood HD, Hsiao CF, Hu N, Hu W, Hu Z, Huang MS, Huerta JM, Hung JY, Hutchinson A, Inskip PD, Jackson RD, Jacobs EJ, Jenab M, Jeon HS, Ji BT, Jin G, Jin L, Johansen C, Johnson A, Jung YJ, Kaaks R, Kamineni A, Kane E, Kang CH, Karagas MR, Kelly RS, Khaw KT, Kim C, Kim HN, Kim JH, Kim JS, Kim YH, Kim YT, Kim YC, Kitahara CM, Klein AP, Klein RJ, Kogevinas M, Kohno T, Kolonel LN, Kooperberg C, Kricker A, Krogh V, Kunitoh H, Kurtz RC, Kweon SS, LaCroix A, Lawrence C, Lecanda F, Lee VH, Li D, Li H, Li J, Li YJ, Li Y, Liao LM, Liebow M, Lightfoot T, Lim WY, Lin CC, Lin D, Lindstrom S, Linet MS, Link BK, Liu C, Liu J, Liu L, Ljungberg B, Lloreta J, Di Lollo S, Lu D, Lund E, Malats N, Mannisto S, Le Marchand L, Marina N, Masala G, Mastrangelo G, Matsuo K, Maynadie M, McKay J, McKean-Cowdin R, Melbye M, Melin BS, Michaud DS, Mitsudomi T, Monnereau A, Montalvan R, Moore LE, Mortensen LM, Nieters A, North KE, Novak AJ, Oberg AL, Offit K, Oh IJ, Olson SH, Palli D, Pao W, Park IK, Park JY, Park KH, Patiño-Garcia A, Pavanello S, Peeters PH, Perng RP, Peters U, Petersen GM, Picci P, Pike MC, Porru S, Prescott J, Prokunina-Olsson L, Qian B, Qiao YL, Rais M, Riboli E, Riby J, Risch HA, Rizzato C, Rodabough R, Roman E, Roupret M, Ruder AM, Sanjose Sd, Scelo G, Schned A, Schumacher F, Schwartz K, Schwenn M, Scotlandi K, Seow A, Serra C, Serra M, Sesso HD, Setiawan VW, Severi G, Severson RK, Shanafelt TD, Shen H, Shen W, Shin MH, Shiraishi K, Shu XO, Siddiq A, Sierrasesúmaga L, Sihoe AD, Skibola CF, Smith A, Smith MT, Southey MC, Spinelli JJ, Staines A, Stampfer M, Stern MC, Stevens VL, Stolzenberg-Solomon RS, Su J, Su WC, Sund M, Sung JS, Sung SW, Tan W, Tang W, Tardón A, Thomas D, Thompson CA, et al. PMID: 26464424; PMCID: PMC4806328.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    123. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch. 2016 Mar; 468(3):259-75. Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E. PMID: 26454445; PMCID: PMC5002945.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimals
    124. The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. J Thorac Oncol. 2015 Oct; 10(10):1383-95. Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, Ströbel P. PMID: 26295375; PMCID: PMC4581965.
      View in: PubMed   Mentions: 268     Fields:    Translation:Humans
    125. Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients - a comparative analysis of total charges and complication rates. Gynecol Oncol. 2015 Nov; 139(2):300-5. Chan JK, Gardner AB, Taylor K, Thompson CA, Blansit K, Yu X, Kapp DS. PMID: 26363212.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    126. The use of clinical characteristics to help prevent morcellation of leiomyosarcoma: An analysis of 491 cases. Am J Obstet Gynecol. 2015 Dec; 213(6):873-4. Chan JK, Gardner AB, Thompson CA, Kapp DS. PMID: 26226552.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1093-1100. Tinkle CL, Weinberg V, Chen LM, Littell R, Cunha JAM, Sethi RA, Chan JK, Hsu IC. PMID: 26194683.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    128. Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients. Gynecol Oncol. 2015 Dec; 139(3):413-8. Fuh KC, Secord AA, Bevis KS, Huh W, ElNaggar A, Blansit K, Previs R, Tillmanns T, Kapp DS, Chan JK. PMID: 26144600.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    129. The centralization of robotic surgery in high-volume centers for endometrial cancer patients--a study of 6560 cases in the U.S. Gynecol Oncol. 2015 Jul; 138(1):128-32. Chan JK, Gardner AB, Taylor K, Blansit K, Thompson CA, Brooks R, Yu X, Kapp DS. PMID: 25933680.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    130. A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Jun; 137(3):386-91. Coleman RL, Sill MW, Bell-McGuinn K, Aghajanian C, Gray HJ, Tewari KS, Rubin SC, Rutherford TJ, Chan JK, Chen A, Swisher EM. PMID: 25818403; PMCID: PMC4447525.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCTClinical Trials
    131. Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study. J Clin Oncol. 2015 May 01; 33(13):1460-6. Tewari D, Java JJ, Salani R, Armstrong DK, Markman M, Herzog T, Monk BJ, Chan JK. PMID: 25800756; PMCID: PMC4404424.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    132. A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer. Gynecol Oncol. 2015 Jun; 137(3):490-6. Minion LE, Bai J, Monk BJ, Robin Keller L, Ramez EN, Forde GK, Chan JK, Tewari KS. PMID: 25766118.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    133. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nat Commun. 2015 Jan 14; 6:6025. Küçük C, Jiang B, Hu X, Zhang W, Chan JK, Xiao W, Lack N, Alkan C, Williams JC, Avery KN, Kavak P, Scuto A, Sen E, Gaulard P, Staudt L, Iqbal J, Zhang W, Cornish A, Gong Q, Yang Q, Sun H, d'Amore F, Leppä S, Liu W, Fu K, de Leval L, McKeithan T, Chan WC. PMID: 25586472; PMCID: PMC7743911.
      View in: PubMed   Mentions: 220     Fields:    Translation:HumansCells
    134. Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. Int J Cancer. 2015 Jul 15; 137(2):311-9. Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD, Chen K, Wang JC, Wen W, Cawthon R, Chatterjee N, Hu W, Caporaso NE, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein RJ, Chung CC, Oh IJ, Chen KY, Berndt SI, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen RC, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wong MP, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF, Zheng W, Lin D, Chanock SJ, Rothman N, Lan Q. PMID: 25516442; PMCID: PMC4733320.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    135. A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancer. Gynecol Oncol. 2015 Jan; 136(1):94-8. Plamadeala V, Kelley JL, Chan JK, Krivak TC, Gabrin MJ, Brower SL, Powell MA, Rutherford TJ, Coleman RL. PMID: 25462203.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    136. Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2208-17. Thompson CA, Gomez SL, Chan A, Chan JK, McClellan SR, Chung S, Olson C, Nimbal V, Palaniappan LP. PMID: 25368396; PMCID: PMC4221799.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    137. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Gynecol Oncol. 2015 Mar; 136(3):491-7. Fuh KC, Shin JY, Kapp DS, Brooks RA, Ueda S, Urban RR, Chen LM, Chan JK. PMID: 25455734.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    138. Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol. 2014 Oct; 38(10):e60-71. Swerdlow SH, Jaffe ES, Brousset P, Chan JK, de Leval L, Gaulard P, Harris NL, Pileri S, Weiss LM, International Lymphoma Study Group. PMID: 25025449; PMCID: PMC6329302.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    139. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas. Am J Obstet Gynecol. 2015 Feb; 212(2):188.e1-6. Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK. PMID: 25149685.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    140. Foreign- vs US-born Asians and the association of type I uterine cancer. Am J Obstet Gynecol. 2015 Jan; 212(1):43.e1-6. Simons E, Blansit K, Tsuei T, Brooks R, Ueda S, Kapp DS, Chan JK. PMID: 25043758.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    141. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014 May; 9(5):596-611. Marx A, Ströbel P, Badve SS, Chalabreysse L, Chan JK, Chen G, de Leval L, Detterbeck F, Girard N, Huang J, Kurrer MO, Lauriola L, Marino M, Matsuno Y, Molina TJ, Mukai K, Nicholson AG, Nonaka D, Rieker R, Rosai J, Ruffini E, Travis WD. PMID: 24722150.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    142. Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions. Am J Surg Pathol. 2014 May; 38(5):646-53. Li XQ, Cheuk W, Lam PW, Wang Z, Loong F, Yeong ML, Browett P, McCall J, Chan JK. PMID: 24503752.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    143. Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis. Oncologist. 2014 May; 19(5):523-7. Chan JK, Herzog TJ, Hu L, Monk BJ, Kiet T, Blansit K, Kapp DS, Yu X. PMID: 24721817; PMCID: PMC4012959.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    144. MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. Gynecol Oncol. 2014 Jun; 133(3):568-74. Chan JK, Kiet TK, Blansit K, Ramasubbaiah R, Hilton JF, Kapp DS, Matei D. PMID: 24680769.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    145. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations. Clin Cancer Res. 2014 Jun 15; 20(12):3078-86. Guo S, Chan JK, Iqbal J, McKeithan T, Fu K, Meng B, Pan Y, Cheuk W, Luo D, Wang R, Zhang W, Greiner TC, Chan WC. PMID: 24634383.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    146. Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews. Oncologist. 2014 Mar; 19(3):299-304. Chan JK, Kiet TK, Monk BJ, Young-Lin N, Blansit K, Kapp DS, Amanam I. PMID: 24599479; PMCID: PMC3958455.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    147. Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care? Gynecol Oncol. 2014 Mar; 132(3):698-702. Lefkowits C, W Rabow M, E Sherman A, K Kiet T, Ruskin R, Chan JK, Chen LM. PMID: 24472408.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    148. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol. 2014 Mar; 132(3):739-44. Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, Bourguignon LY. PMID: 24472409.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    149. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol. 2014 Jan; 123(1):65-72. Chan JK, Urban R, Capra AM, Jacoby V, Osann K, Whittemore A, Habel LA. PMID: 24463665; PMCID: PMC4624417.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    150. Impact of facility volume on therapy and survival for locally advanced cervical cancer. Gynecol Oncol. 2014 Feb; 132(2):416-22. Lin JF, Berger JL, Krivak TC, Beriwal S, Chan JK, Sukumvanich P, Monk BJ, Richard SD. PMID: 24333361.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    151. Diagnosis of brainstem involvement in NK/T cell lymphoma. Ann Hematol. 2014 Aug; 93(8):1433-4. So JC, Chan KH, Pang AW, Chan JK, Kwong YL. PMID: 24292537.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    152. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review. Diagn Pathol. 2013 Sep 13; 8:147. Li J, Yin WH, Takeuchi K, Guan H, Huang YH, Chan JK. PMID: 24034896; PMCID: PMC3850018.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    153. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012 Dec; 44(12):1330-5. Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF, Lin D, Chanock SJ, Rothman N. PMID: 23143601; PMCID: PMC4169232.
      View in: PubMed   Mentions: 183     Fields:    Translation:HumansCells
    154. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. PMID: 23129514.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    155. The management of small-cell carcinomas of the gynecologic tract. Curr Opin Oncol. 2012 Sep; 24(5):572-9. Cohen JG, Chan JK, Kapp DS. PMID: 22820410.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    156. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-131. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. PMID: 22892364.
      View in: PubMed   Mentions: 4     Fields:    
    157. Characteristics of success in mentoring and research productivity - a case-control study of academic centers. Gynecol Oncol. 2012 Apr; 125(1):8-13. Cohen JG, Sherman AE, Kiet TK, Kapp DS, Osann K, Chen LM, O'Sullivan PS, Chan JK. PMID: 22252098.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    158. An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals. Gynecol Oncol. 2012 Apr; 125(1):237-40. Venkat P, Chen LM, Young-Lin N, Kiet TK, Young G, Amatori D, Dasverma B, Yu X, Kapp DS, Chan JK. PMID: 22120176.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    159. An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer. Gynecol Oncol. 2012 Feb; 124(2):199-204. Dalton HJ, Yu X, Hu L, Kapp DS, Benjamin I, Monk BJ, Chan JK. PMID: 22055763.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    160. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011 Mar 01; 29(7):832-8. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, Chen LM, Deshmukh H. PMID: 21263082.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    161. Idiopathic cervical fibrosis--a new member of IgG4-related sclerosing diseases: report of 4 cases, 1 complicated by composite lymphoma. Am J Surg Pathol. 2010 Nov; 34(11):1678-85. Cheuk W, Tam FK, Chan AN, Luk IS, Yuen AP, Chan WK, Hung TC, Chan JK. PMID: 20871392.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    162. American Society of Clinical Oncology 2010 Annual Meeting update: summary of selected gynecologic cancer abstracts. Gynecol Oncol. 2010 Sep; 118(3):216-9. Monk BJ, Chan JK. PMID: 20722100.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    163. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010 Oct; 203(4):347.e1-6. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. PMID: 20579961.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    164. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):301-6. Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J. PMID: 19945740.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    165. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):307-11. Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J. PMID: 19944452.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    166. Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol. 2009 Dec; 115(3):357-61. Chen LM, Weinberg VK, Chen C, Powell CB, Chen LL, Chan JK, Burkhardt DH. PMID: 19783285.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    167. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. PMID: 19679341.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    168. Cost effectiveness of a test to detect metastases for endometrial cancer. Gynecol Oncol. 2009 Mar; 112(3):526-30. Havrilesky LJ, Maxwell GL, Chan JK, Myers ER. PMID: 19100608.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    169. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008 Oct 21; 99(8):1210-5. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. PMID: 18813312; PMCID: PMC2570503.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    170. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008 Sep; 20(5):565-9. Sugiyama VE, Chan JK, Kapp DS. PMID: 19106662.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    171. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008 Aug 01; 98(2):111-6. Chan JK, Tewari KS, Waller S, Cheung MK, Shin JY, Osann K, Kapp DS. PMID: 18563734; PMCID: PMC4111627.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    172. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008 May 15; 112(10):2202-10. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC, Gynecologic Oncology Group. PMID: 18348296.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    173. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008 Jun; 109(3):370-6. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. PMID: 18395777.
      View in: PubMed   Mentions: 189     Fields:    Translation:HumansCells
    174. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 08; 98(7):1191-6. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. PMID: 18349835; PMCID: PMC2359639.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    175. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? J Clin Oncol. 2008 Mar 20; 26(9):1511-8. Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS. PMID: 18285603.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    176. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008 Feb 15; 112(4):820-30. Kapp DS, Shin JY, Chan JK. PMID: 18189292.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    177. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol. 2008 Feb 01; 97(2):103-7. Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS. PMID: 17979133.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    178. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008 Feb; 198(2):218.e1-6. Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK. PMID: 18226630.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    179. Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol. 2008 Feb; 20(1):26-33. Hamilton CA, Kapp DS, Chan JK. PMID: 18197002.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    180. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Am J Obstet Gynecol. 2008 Feb; 198(2):216.e1-5. Chan JK, Kapp DS, Cheung MK, Shin JY, Stieglitz D, Husain A, Teng NN, Berek JS, Osann K, Guo H. PMID: 18226629.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    181. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Obstet Gynecol. 2007 Dec; 110(6):1237-43. Parthasarathy A, Kapp DS, Cheung MK, Shin JY, Osann K, Chan JK. PMID: 18055715.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    182. A novel technique for the enrichment of primary ovarian cancer cells. Am J Obstet Gynecol. 2007 Nov; 197(5):507.e1-5. Chan JK, Hamilton CA, Anderson EM, Cheung MK, Baker J, Husain A, Teng NN, Kong CS, Negrin RS. PMID: 17980191.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    183. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):95-9. Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. PMID: 17949796.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    184. Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol. 2007 Sep; 8(9):831-41. Chan JK, Kapp DS. PMID: 17765192.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    185. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007 Aug; 106(2):282-8. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. PMID: 17662377.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    186. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):296-301. Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. PMID: 17666603.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    187. Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol. 2007 Jul 10; 25(20):2975-82. Chan JK, Berek JS. PMID: 17617529.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    188. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer. 2007 Jun 15; 109(12):2454-60. Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K. PMID: 17503431.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    189. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007 Jun; 109(6):1342-50. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O'Malley C. PMID: 17540806.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    190. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007 Jun 18; 96(12):1817-22. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS. PMID: 17519907; PMCID: PMC2359970.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    191. Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California. Int J Cancer. 2007 Mar 15; 120(6):1324-9. Keegan TH, Gomez SL, Clarke CA, Chan JK, Glaser SL. PMID: 17163416.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    192. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007 Mar; 109(3):655-62. Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK. PMID: 17329517.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    193. Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2007 Apr; 105(1):194-8. Zhang MM, Chan JK, Husain A, Guo HY, Teng NN. PMID: 17257661.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    194. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007 Jan; 109(1):12-9. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K. PMID: 17197582.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    195. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007 Mar; 104(3):636-41. Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, Cheung MK, Berman ML, Disaia PJ. PMID: 17095080.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    196. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006 Oct 15; 107(8):1823-30. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. PMID: 16977653.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    197. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Gynecol Oncol. 2007 Feb; 104(2):396-400. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK. PMID: 17030354.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    198. Validity of cancer registry medicaid status against enrollment files: implications for population-based studies of cancer outcomes. Med Care. 2006 Oct; 44(10):952-5. Chan JK, Gomez SL, O'Malley CD, Perkins CI, Clarke CA. PMID: 17001267.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    199. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):521-8. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K. PMID: 16946210.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    200. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol. 2006 Dec; 103(3):1095-9. Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, Kapp DS, Chan JK. PMID: 16889821.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    201. Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma. Gynecol Oncol. 2006 Dec; 103(3):919-23. Chan JK, Manuel MR, Ciaravino G, Cheung MK, Husain A, Teng NN. PMID: 16828852.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    202. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol. 2006 Nov; 103(2):679-83. Hamilton CA, Cheung MK, Osann K, Balzer B, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. PMID: 16793126.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    203. Outcomes of women with metachronous breast and ovarian carcinomas. Gynecol Oncol. 2006 Oct; 103(1):190-4. Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK. PMID: 16569424.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    204. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res. 2006 Mar 15; 12(6):1859-67. Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. PMID: 16551871.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    205. Juvenile granulosa cell tumor of the ovary associated with tuberous sclerosis. Gynecol Oncol. 2006 Jul; 102(1):118-20. Guo H, Keefe KA, Kohler MF, Chan JK. PMID: 16516278.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    206. Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes? Gynecol Oncol. 2006 Sep; 102(3):508-12. Chan JK, Manuel MR, Cheung MK, Osann K, Husain A, Teng NN, Rao A, Carlson RW, Whittemore AS. PMID: 16483640.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    207. Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors. Obstet Gynecol. 2006 Feb; 107(2 Pt 1):329-35. Zhang MM, Cheung MK, Osann K, Lee MM, Gomez SS, Whittemore AS, Husain A, Teng NN, Chan JK. PMID: 16449120.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    208. Innovations in fertility preservation for patients with gynecologic cancers. Fertil Steril. 2005 Dec; 84(6):1561-73. Liou WS, Yap OW, Chan JK, Westphal LM. PMID: 16359944.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    209. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):839-44. Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. PMID: 16199314.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    210. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol. 2005 Oct; 99(1):20-5. Chan JK, Magistris A, Loizzi V, Lin F, Rutgers J, Osann K, DiSaia PJ, Samoszuk M. PMID: 16055178.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    211. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer. J Clin Oncol. 2005 Sep 20; 23(27):6794-5. Chan JK, Lin SS, McMeekin DS, Berman ML. PMID: 16170188.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    212. Clinicopathologic features of six cases of primary cervical lymphoma. Am J Obstet Gynecol. 2005 Sep; 193(3 Pt 1):866-72. Chan JK, Loizzi V, Magistris A, Hunter MI, Rutgers J, DiSaia PJ, Berman ML. PMID: 16150291.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    213. A modified technique for insertion of intraperitoneal port for chemotherapy. J Surg Oncol. 2005 Jun 15; 90(4):247-8. Liou WS, Teng NN, Chan JK. PMID: 15906367.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    214. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model. Cancer Res. 2005 Apr 15; 65(8):3243-8. Chan JK, Pham H, You XJ, Cloven NG, Burger RA, Rose GS, Van Nostrand K, Korc M, Disaia PJ, Fan H. PMID: 15833856.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    215. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis. Gynecol Oncol. 2005 Jan; 96(1):204-9. Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, Disaia PJ. PMID: 15589602.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    216. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer. Clin Cancer Res. 2004 Dec 15; 10(24):8538-43. Chan JK, Loizzi V, Magistris A, Lin F, Rutgers J, Osann K, Disaia PJ, Berman ML. PMID: 15623636.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    217. Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004 Oct; 95(1):152-6. Chan JK, Sugiyama V, Tajalli TR, Pham H, Gu M, Rutgers J, Monk BJ. PMID: 15385125.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    218. Oral altretamine used as salvage therapy in recurrent ovarian cancer. Gynecol Oncol. 2004 Jan; 92(1):368-71. Chan JK, Loizzi V, Manetta A, Berman ML. PMID: 14751188.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    219. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003 Dec 02; 139(11):879-92. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK. PMID: 14644890.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    220. Modified technique for suprapubic catheter insertion that avoids urinary leakage. Am J Obstet Gynecol. 2003 Dec; 189(6):1670-1. Berman ML, Truong TH, DiSaia PJ, Chan JK. PMID: 14710096.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    221. Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol. 2003 Nov; 189(5):1301-7. Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, Berman ML. PMID: 14634558.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    222. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med. 2003 Oct; 48(10):756-60. Chan JK, Lin YG, Loizzi V, Ghobriel M, DiSaia PJ, Berman ML. PMID: 14619640.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    223. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003 Jul 01; 98(1):31-40. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. PMID: 12833452.
      View in: PubMed   Mentions: 237     Fields:    Translation:Humans
    224. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol. 2003 Jul; 102(1):156-61. Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ. PMID: 12850623.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    225. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003 Jul; 90(1):181-5. Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML. PMID: 12821361.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    226. Prevention of ureteral injuries in gynecologic surgery. Am J Obstet Gynecol. 2003 May; 188(5):1273-7. Chan JK, Morrow J, Manetta A. PMID: 12748497.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    227. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer. 2003 Feb 01; 97(3):568-74. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. PMID: 12548598.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    228. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002 Nov 01; 100(9):3415-8. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabeçadas J, Dong HY, Harris NL, Chan JK, Rees JW, Dogan A, Isaacson PG. PMID: 12384445.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    229. Endometrial stromal sarcoma of the retroperitoneum. Ann Diagn Pathol. 2002 Oct; 6(5):312-8. Morrison C, Ramirez NC, Chan JK, Wakely P. PMID: 12376925.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    230. Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model. Gynecol Oncol. 2002 Oct; 87(1):64-70. Chan JK, Monk BJ, Cuccia D, Pham H, Kimel S, Gu M, Hammer-Wilson MJ, Liaw LH, Osann K, DiSaia PJ, Berns M, Tromberg B, Tadir Y. PMID: 12468344.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    231. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002 Sep 01; 54(1):182-90. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. PMID: 12182990.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    232. Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature. Cancer. 2002 Jan 15; 94(2):398-405. Ngan RK, Yiu HH, Cheng HK, Chan JK, Sin VC, Lau WH. PMID: 11905411.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    233. Prevention of femoral nerve injuries in gynecologic surgery. Am J Obstet Gynecol. 2002 Jan; 186(1):1-7. Chan JK, Manetta A. PMID: 11810076.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    John's Networks
    Concepts (633)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (44)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.